Watched this concerning...

Watched this concerning STJ

http://video.cnbc.com/gallery/?play=1&video=3000209107

STJ great results for new products.
But C-Pulse may be dominant in a complimentary treatment partnership or it may supersede.
(hope to chat to management about this.)
STJ 38% reduction in hospitalisations, C-Pulse 100% reduction plus reversal.
Maybe that is why Crammer is observing a little flatness in an otherwise super story.
The STJ bloke would know the story if the probably correct rumour that STJ is one of the three mega medical companies with shares in SSH is true.
Is he enjoying the last days in the sun.
Maybe a bit early to think the word is getting out, Crammer hasn't got it.
Positives at TCT will really boost the story.

Given
European German update.

On horizon??
US trial update.
Other sites in Europe.
Fully implantable update.


Money in the bank